Drugmaker Eli Lilly announced Wednesday it will reduce prices for some of its most commonly prescribed insulin products by up by to 70%, and expand a monthly $35 cap on prescription costs for insured patients. CBS News correspondent Lilia Luciano reported on the government’s role in the process.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
